Functional analysis of the two reciprocal fusion genes MLL-NEBL and NEBL-MLL reveal their oncogenic potential

Cancer Letters

Volumn 332, Issue 1, 2013, Pages 30-34

  Emerenciano, Mariana ^a,b   Kowarz, Eric ^b   Karl, Katharina ^b   De Almeida Lopes, Bruno ^a   Scholz, Bastian ^b   Bracharz, Silvia ^b   Meyer, Claus ^b   Pombo de Oliveira, Maria S ^a   Marschalek, Rolf ^b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Infant leukemia; MLL; NEBL

Indexed keywords

HYBRID PROTEIN; LASP1 PROTEIN; MESSENGER RNA; MIXED LINEAGE LEUKEMIA PROTEIN; NEBL PROTEIN; NEBULIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; FUSION GENE; GENETIC ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MLL-NEBL GENE; MOUSE; MULTIGENE FAMILY; NEBL MLL GENE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CARRIER PROTEINS; CELL PROLIFERATION; CELL SHAPE; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FUSION; GENOTYPE; HEK293 CELLS; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; LIM DOMAIN PROTEINS; MICE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; ONCOGENE PROTEINS, FUSION; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 84875275978     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.12.023     Document Type: Article

References (16)

1. Meyer C., Kowarz E., Hofmann J., Renneville A., Zuna J., Trka J., et al. New insights into the MLL recombinome of acute leukemias. Leukemia 2009, 23:1490-1499.
2. Corral J., Lavenir I., Impey H., Warren A.J., Forster A., Larson T.A., et al. An MLL-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice. a method to create fusion oncogenes. Cell 1996, 85:853-861.
3. Lavau C., Szilvassy S.J., Slany R., Cleary M.L. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 1997, 16:4226-4237.
4. Lavau C., Luo R.T., Du C., Thirman M.J. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. Proc. Natl. Acad. Sci. USA 2000, 97:10984-10989.
5. DiMartino J.F., Ayton P.M., Chen E.H., Naftzger C.C., Young B.D., Cleary M.L. The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood 2002, 99:3780-3785.
6. Krivtsov A.V., Feng Z., Lemieux M.E., Faber J., Vempati S., Sinha A.U., et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell 2008, 14:355-368.
7. Liedtke M., Ayton P.M., Somervaille T.C.P., Smith K.S., Cleary M.L. Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6. Blood 2010, 116:63-70.
8. Bursen A., Schwabe K., Rüster B., Henschler R., Ruthardt M., Dingermann T., et al. AF4-MLL is capable of inducing ALL in mice without requirement of MLL-AF4. Blood 2010, 115:3570-3579.
9. Marschalek R. Mechanisms of leukemogenesis by MLL fusion proteins. Br. J. Haematol. 2011, 152:141-154.
10. Coser V., Meyer C., Basegio R., Menezes J., Marschalek R., Pombo-de-Oliveira M.A. Nebulette is the second member of the Nebulin family fused to the MLL gene in infant leukemia. Cancer Genet. Cytogenet. 2010, 198:151-154.
11. Katoh M., Katoh M. Identification and characterization of LASP2 gene in silico. Int. J. Mol. Med. 2003, 12:405-410.
12. Li B., Zhuang L., Trueb B. Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1. J. Biol. Chem. 2004, 279:20401-20410.
13. Deng X.A., Norris A., Panaviene Z., Moncman C.L. Ectopic expression of LIM-nebulette (LASP2) reveals roles in cell migration and spreading. Cell Motil. Cytoskeleton 2008, 65:827-840.
14. Strehl S., Borkhardt A., Slany R., Fuchs U.E., König M., Haas O.A. The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21). Oncogene 2003, 22:157-160.
15. Bursen A., Moritz S., Gaussmann A., Dingermann T., Marschalek R. Interaction of AF4 wildtype and AF4•MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?. Oncogene 2004, 23:6237-6249.
16. Gaussmann A., Wenger T., Eberle I., Bursen A., Bracharz S., Herr I., et al. Combined effects of the two reciprocal t(4;11) fusion proteins MLL•AF4 and AF4•MLL confer resistance to apoptosis, cell cycling capacity and growth transformation. Oncogene 2007, 26:3352-3363.